Systematic Review: SARS‐CoV‐2‐neutralising monoclonal antibodies to prevent COVID‐19.
SARS‐CoV‐2‐neutralising monoclonal antibodies to prevent COVID‐19 – Cochrane Library Summary: Are laboratory-made COVID-19-specific monoclonal antibodies effective to prevent COVID-19 in adults? – Cochrane Library
The post Systematic Review: SARS‐CoV‐2‐neutralising monoclonal antibodies to prevent COVID‐19. appeared first on Links Medicus.
Ivermectin for COVID-19 Cochrane review update: 11 trials and no evidence of benefit shown.
News Release: Ivermectin for COVID-19 review update: 11 trials and no evidence of benefit shown – Liverpool School of Tropical Medicine Original Article: Ivermectin for preventing and treating COVID‐19 – Cochrane Library Summary: Ivermectin for preventing and treating COVID-19 – Cochrane Library
The post Ivermectin for COVID-19 Cochrane review update: 11 trials and no evidence of benefit shown. appeared first on Links Medicus.
Review: Sex differences in sequelae from COVID-19 infection and in long COVID syndrome.
Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review – Current Medical Research and Opinion Commentary: Women more likely to have long COVID, different symptom profile – CIDRAP
The post Review: Sex differences in sequelae from COVID-19 infection and in long COVID syndrome. appeared first on Links Medicus.
ASA and APSF statement on perioperative testing for the COVID-19 virus.
ASA and APSF Statement on Perioperative Testing for the COVID-19 Virus – American Society of Anesthesiologists Commentary: ASA, APST Update Perioperative SARS-CoV-2 Testing Recommendations – HealthDay Related: Surgical Triage and Timing for Patients with COVID: A Guidance Statement from the Society of Thoracic Surgeons – Annals of Thoracic Surgery When to operate after SARS-CoV-2 infection? […]
The post ASA and APSF statement on perioperative testing for the COVID-19 virus. appeared first on Links Medicus.
Randomized cross-over study: closed-loop oxygen control improves oxygen therapy in acute hypoxemic respiratory failure patients under high flow nasal oxygen.
Closed-loop oxygen control improves oxygen therapy in acute hypoxemic respiratory failure patients under high flow nasal oxygen: a randomized cross-over study (the HILOOP study) – Critical Care
The post Randomized cross-over study: closed-loop oxygen control improves oxygen therapy in acute hypoxemic respiratory failure patients under high flow nasal oxygen. appeared first on Links Medicus.
RCT: High-flow nasal cannula vs. conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia.
High-flow nasal cannula versus conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia: a multicenter randomized controlled trial – Critical Care
The post RCT: High-flow nasal cannula vs. conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia. appeared first on Links Medicus.
RCT: Efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes.
Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Type 2 Diabetes: A Randomized Clinical Trial – JAMA Network Open Author Interview: Efficacy and Safety of Varenicline in Patients With Type 2 Diabetes – JAMA Commentary on Twitter This randomized clinical trial (CoEHAR) found the use of varenicline in smoking cessation programs […]
The post RCT: Efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes. appeared first on Links Medicus.
How common is long COVID? Why studies give different answers.
How common is long COVID? Why studies give different answers – Nature
The post How common is long COVID? Why studies give different answers. appeared first on Links Medicus.
RCT: Low-dose methylprednisolone does not improve outcomes in critically ill patients with severe community-acquired pneumonia.
Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia – Intensive Care Medicine
The post RCT: Low-dose methylprednisolone does not improve outcomes in critically ill patients with severe community-acquired pneumonia. appeared first on Links Medicus.
[Preprint] Open-label RCT: Baricitinib noninferior to Tocilizumab in hospitalized patients with severe COVID-19.
Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial – medRxiv Related: Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial – The Lancet Respiratory Medicine Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated […]
The post [Preprint] Open-label RCT: Baricitinib noninferior to Tocilizumab in hospitalized patients with severe COVID-19. appeared first on Links Medicus.